ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Calquence 100 mg, Hartkapseln - 60
67790001 AstraZeneca AG
Calquence 100 mg, Hartkapseln04.03.2021
  04.03.2021
Acalabrutinib (L01EL02) 
WHO-DDD03.03.2026
07.16.10.60
07.16.10. 
A  
Yes 
IPCI
4526.77Yes
    
10 %4939.55
7680677900013Synthetika
  
Composition
acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum A corresp. natrium max. 0.25 mg, magnesii stearas, Kapselhülle: gelatina, E 172 (flavum), E 132, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Acalabrutinibum100 mg
BAG: Active AgentDose
Acalabrutinibum100 mg
 
Inactive agents additional_information
(Flavum)  
(Nigrum)  
Ammonii Hydroxidum  
Amylum Pregelificatum  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum Silicificatum  
E 132 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Magnesii Stearas  
Pro Capsula  
Propylenglycol  
 
Source
Data was imported : 12.05.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home